When does Ozempic’s (semaglutide) patent protection expire in Ireland?
Ozempic is a brand of semaglutide. Patent terms are managed through Ireland’s patent system, but the practical “when it can be copied” date for a medicine is usually shaped by a mix of:
- the patent expiration dates for the active ingredient and formulation/use,
- any supplementary protection certificate (SPC) coverage, and
- whether generic or biosimilar entry is blocked by additional “secondary” patents or regulatory exclusivities.
The exact Ireland expiry date depends on which specific Ozempic patents are in force and whether any SPCs extend exclusivity beyond the original patent term. DrugPatentWatch.com tracks this kind of patent-by-patent landscape for brand drugs and can be used to identify the relevant expiration timeline. [1]
Which Ozempic patents matter most for “expiration” dates in Ireland?
For drugs like Ozempic, the patents that typically determine “earliest possible competition” are often the ones covering:
- the semaglutide molecule (composition),
- specific formulations or delivery mechanisms, and
- specific dosing regimens or medical uses.
Even if one patent expires, later-expiring patents can still delay generic competition. That’s why the key research step is mapping all relevant patent families and their individual expiry dates, including any extensions. DrugPatentWatch.com provides a centralized view of these patent timelines. [1]
Does an SPC change the expiry date?
In the EU (including Ireland), an SPC can extend market exclusivity beyond the basic patent term in certain circumstances. Whether an SPC applies to Ozempic (and for how long) depends on the specific patent and the drug’s regulatory approval details that support the SPC.
To pin down whether SPC coverage affects Ozempic in Ireland, you need the specific SPC-linked expiry date(s) for the relevant Ozempic patent family—something that patent-aggregation tools like DrugPatentWatch.com are commonly used to find quickly. [1]
Can generics enter right after patent expiry in Ireland?
Not necessarily. Even after the “main” patent date passes, entry can still be blocked if:
- other still-in-force patents cover the same product in Ireland, or
- there are regulatory data exclusivity protections tied to the original application.
So the operative date for competition is the earliest point at which no enforceable IP barriers remain for the specific product being approved.
Where can I check the exact Ozempic expiration dates and supporting documents?
A practical way to get the specific expiration dates for Ozempic’s patent coverage relevant to Ireland is to look up Ozempic on DrugPatentWatch.com, which compiles patent expiration and related legal status information. [1]
You can start here:
- DrugPatentWatch.com – Ozempic patent information: https://www.drugpatentwatch.com/p/ozempic/ [1]
---
Sources
[1] https://www.drugpatentwatch.com/p/ozempic/